Kura Oncology Inc (KURA)

EBITDA Growth

-3.21%

Quarterly · Period ending:

KURA logo

KURA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-3.21%
KURA Quarterly EBITDA YoY % (7.13% → -3.21%)
High-resolution chart · PNG

KURA ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Kura Oncology Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-3.2073%
-26.6636%
-383.2389%
-37.4981%
-30.4167%
-17.2847%
60.662%
-41.6039%
-37.3353%
-45.9536%
-29.0676%
-7.5642%
-5.748%
-3.7892%
-0.3131%
-6.3392%
-4.0713%
-5.8993%
-25.7459%
-41.0081%
-63.4597%
-59.8552%
-46.1773%
-44.966%
-37.4413%
-38.2345%
-11.4374%
-10.1023%
-2.2429%
3.8247%
-51.5966%
-62.1319%
-90.2933%
-95.8618%
-46.83%
-35.3361%
-12.0725%
-4.124%
-4.5355%
-4.7189%
-14.9051%
-50.0961%
-79,478.5307%
-112,528.7676%
-113,118.9464%
-11.6324%
100%
3.9223%
12.2561%
18.7968%
5.3511%
-9.2074%
-11.2002%
-87.8097%
11.791%
50.5542%
50.293%
65.0333%
36.7626%
1.3474%
-8.3841%
53.7949%
-44.457%
7.129%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.